Segal S - Search Results

1

CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells.

Song X, Krelin Y, Dvorkin T, Bjorkdahl O, Segal S, Dinarello CA, Voronov E, Apte RN. Song X, et al. Among authors: segal s. J Immunol. 2005 Dec 15;175(12):8200-8. doi: 10.4049/jimmunol.175.12.8200. J Immunol. 2005. PMID: 16339559

2

Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.

Song X, Voronov E, Dvorkin T, Fima E, Cagnano E, Benharroch D, Shendler Y, Bjorkdahl O, Segal S, Dinarello CA, Apte RN. Song X, et al. Among authors: segal s. J Immunol. 2003 Dec 15;171(12):6448-56. doi: 10.4049/jimmunol.171.12.6448. J Immunol. 2003. PMID: 14662844

3

Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions.

Apte RN, Krelin Y, Song X, Dotan S, Recih E, Elkabets M, Carmi Y, Dvorkin T, White RM, Gayvoronsky L, Segal S, Voronov E. Apte RN, et al. Among authors: segal s. Eur J Cancer. 2006 Apr;42(6):751-9. doi: 10.1016/j.ejca.2006.01.010. Epub 2006 Mar 10. Eur J Cancer. 2006. PMID: 16530403 Review.

4

Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1alpha.

Dvorkin T, Song X, Argov S, White RM, Zoller M, Segal S, Dinarello CA, Voronov E, Apte RN. Dvorkin T, et al. Among authors: segal s. J Leukoc Biol. 2006 Jul;80(1):96-106. doi: 10.1189/jlb.0905509. Epub 2006 May 17. J Leukoc Biol. 2006. PMID: 16707560

5

Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.

Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA, Apte RN. Krelin Y, et al. Among authors: segal s. Cancer Res. 2007 Feb 1;67(3):1062-71. doi: 10.1158/0008-5472.CAN-06-2956. Cancer Res. 2007. PMID: 17283139

6

Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice.

Hacham M, Argov S, White RM, Segal S, Apte RN. Hacham M, et al. Among authors: segal s. Eur Cytokine Netw. 2002 Jan-Mar;13(1):55-65. Eur Cytokine Netw. 2002. PMID: 11956021 Free article.

7

Regulation of interleukin 1 generation in immune-activated fibroblasts.

Huleihel M, Douvdevani A, Segal S, Apte RN. Huleihel M, et al. Among authors: segal s. Eur J Immunol. 1990 Apr;20(4):731-8. doi: 10.1002/eji.1830200404. Eur J Immunol. 1990. PMID: 2189735

8

Complementary organ expression of IL-1 vs. IL-6 and CSF-1 activities in normal and LPS-injected mice.

Hacham M, Cristal N, White RM, Segal S, Apte RN. Hacham M, et al. Among authors: segal s. Cytokine. 1996 Jan;8(1):21-31. doi: 10.1006/cyto.1995.0004. Cytokine. 1996. PMID: 8742063

9

Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.

Voronov E, Weinstein Y, Benharroch D, Cagnano E, Ofir R, Dobkin M, White RM, Zoller M, Barak V, Segal S, Apte RN. Voronov E, et al. Among authors: segal s. Cancer Res. 1999 Mar 1;59(5):1029-35. Cancer Res. 1999. PMID: 10070959

10

Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness.

Apte RN, Dvorkin T, Song X, Fima E, Krelin Y, Yulevitch A, Gurfinkel R, Werman A, White RM, Argov S, Shendler Y, Bjorkdahl O, Dohlsten M, Zoller M, Segal S, Voronov E. Apte RN, et al. Among authors: segal s. Adv Exp Med Biol. 2000;479:277-88. Adv Exp Med Biol. 2000. PMID: 10897428 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,632 results

Search Page

Filters